Show simple item record

P450 3A activity and cyclosporine dosing in kidney and heart transplant recipients

dc.contributor.authorTurgeon, D Kimen_US
dc.contributor.authorLeichtman, Alan Ben_US
dc.contributor.authorLown, Kenneth Sen_US
dc.contributor.authorNormolle, Daniel Pen_US
dc.contributor.authorDeeb, G Michaelen_US
dc.contributor.authorMerion, Robert Men_US
dc.contributor.authorWatkins, Paul Ben_US
dc.date.accessioned2015-01-07T15:23:46Z
dc.date.available2015-01-07T15:23:46Z
dc.date.issued1994-09en_US
dc.identifier.citationTurgeon, D Kim; Leichtman, Alan B; Lown, Kenneth S; Normolle, Daniel P; Deeb, G Michael; Merion, Robert M; Watkins, Paul B (1994). "P450 3A activity and cyclosporine dosing in kidney and heart transplant recipients." Clinical Pharmacology & Therapeutics 56(3): 253-260.en_US
dc.identifier.issn0009-9236en_US
dc.identifier.issn1532-6535en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/109917
dc.publisherWiley Periodicals, Inc.en_US
dc.titleP450 3A activity and cyclosporine dosing in kidney and heart transplant recipientsen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelPharmacy and Pharmacologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/109917/1/cptclpt1994135.pdf
dc.identifier.doi10.1038/clpt.1994.135en_US
dc.identifier.sourceClinical Pharmacology & Therapeuticsen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.